Oct 27, 2011

Posted by in Penny Stock | 0 Comments

Penny Stocks with High Volume – MILV:OTC

MILV:OTC – Mistral Ventures Inc

Penny Stocks with High VolumePenny stocks with high volume, Mistral Ventures Inc (MILV:OTC) rallies Thursday on massive trading volume and price action activity.  One to keep a close eye on over the short term!  Nature’s Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. (MILV.OTC) announced that it has reached an agreement with the inventor of a spectacular cold and flu medicine that has been in development for many years.

ALERT ***MILV*** Penny Stocks With High Volume

About Nature’s Bioceuticals:

Nature’s Bioceuticals develops and acquires the rights to natural medicine formulas that are geared towards treating specific medical conditions.

These medicines are all natural and derived from botanicals and mineral bases. Nature’s Bioceuticals strives to provide high quality natural medicines that are as effective, if not more effective, than synthetic drugs and more importantly do not have the negative side effects usually associated with many of today’s prescribed drugs.

Nature’s line of natural medicines will be either sold as prescription drugs, if applied for by the company and approved by the FDA, or sold as dietary supplements under the Dietary Supplement Health and Education Act of 1994, commonly referred to as “DSHEA.”

To become more familiar with the company, please visit their website here: http://www.naturesbioceuticals.com/
Just last week, on Oct 20, Mistral Ventures Inc (MILV:OTC) announced the acquisition of Nature’s Bioceuticals through a share exchange agreement. Former shareholders of Nature’s Bioceticals will control approximately 71% of MILV shares, which lack of a better term has initiated a reverse takeover. Ever since then MILV shares have been under heavy accumulation with price action on the rise triggering a large promotion is under-way.

Penny Stocks with High Volume Heating Up

Penny stocks with high volume such as MILV started to heat up on Wednesday which experienced more than four million shares traded thanks to a stock awareness program hence launched a project that caught all traders and investors on Wall Street. Mistral Ventures, Inc., incorporated on May 13, 2005, is a development-stage company. The Company was engaged in the acquisition, exploration and development of natural resource properties.
In October 2011, the Company acquired 100% interest in Nature’s Bioceuticals, Inc.
Robert deZanger, CEO of Natures Bioceuticals stated, Although the Cold and Flu market is flooded with a number of established brands, we are confident that we can capture a significant portion of the market with an all natural product that really works.

The company has the potential to capture 3% of the US market within a 3 year period, which would potentially generate over $100,000,000 in revenues for the company.

Rewinding back, OTC products have not shown impressive results due to their bad press, a number of recalls and FDA recommendations. In on March 2, 2011 the FDA decided to remove over 500 prescription cold, cough, and allergy products from the market, stating potential safety concerns.
The company stated that its innovation contains over twenty different herbs that are all ‘active ingredients,’ which would be sufficient to provide relief from the cold and flu symptoms, but more importantly, it boosts the body’s immune response to combat the cause of the virus.

Mistral Ventures, MILV are soaring Thursday morning…fire on all cylinders rising over $.01 or 20% to $.055 on massive volume of 160,100,000 shares traded falling into the category of penny stocks with high volume triggering many traders scans on an intraday alert.

Again, Keep a close eye on the close as this could potentially offer more significant gains to come.

Please make note StockRunway.com has not been compensated for this featured advertisement article on Mistral Ventures/Nature’s Bioceutical.

The Captain is signing off for now…

Trade Smart, Be Disciplined and Stay Onboard the StockRunway!

Find more information on penny stocks with high volume on the FREE email list:

Comments are closed.